Hepatic arterial infusion chemotherapy combined with pd-1 inhibitors and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a tertiary medical center experience

HIGHLIGHTS

• who: Laihui Luo from the China Iuliu Hau021bieganu of Medicine China have published the research: Hepatic arterial infusion chemotherapy combined with PD-1 inhibitors and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: A tertiary medical center experience, in the Journal: (JOURNAL)
• what: The authors aimed to evaluate the clinical efficacy and safety of the triple regimen of HAIC, PD-1 inhibitors and TKIs for u-HCC patients in a retrospective study of single-center. The authors reported 145 patients with initially unresectable HCC who received HAIC plus PD-1 inhibitors and TKIs with CR of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.